
electroCore, Inc. (NASDAQ:ECOR – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2026 earnings per share estimates for electroCore in a research note issued to investors on Thursday, May 7th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($0.50) per share for the quarter, down from their previous estimate of ($0.48). HC Wainwright currently has a “Buy” rating and a $18.00 target price on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.46) per share. HC Wainwright also issued estimates for electroCore’s Q3 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($1.49) EPS and FY2027 earnings at ($0.67) EPS.
electroCore (NASDAQ:ECOR – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.59). The firm had revenue of $9.58 million for the quarter, compared to analysts’ expectations of $9.01 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%.
View Our Latest Stock Report on ECOR
electroCore Stock Up 3.1%
Shares of ECOR stock opened at $6.61 on Tuesday. The stock has a market cap of $54.86 million, a price-to-earnings ratio of -3.73 and a beta of 0.68. The business’s fifty day moving average is $6.54 and its 200 day moving average is $5.90. electroCore has a twelve month low of $4.16 and a twelve month high of $8.64.
Institutional Investors Weigh In On electroCore
Several institutional investors have recently modified their holdings of the business. WealthShield Partners LLC purchased a new stake in shares of electroCore during the first quarter valued at $157,000. DRW Securities LLC purchased a new stake in shares of electroCore during the fourth quarter valued at $264,000. Tejara Capital Ltd purchased a new stake in shares of electroCore during the fourth quarter valued at $450,000. International Assets Investment Management LLC boosted its position in shares of electroCore by 15.2% during the fourth quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock valued at $398,000 after buying an additional 11,700 shares during the last quarter. Finally, FNY Investment Advisers LLC purchased a new stake in shares of electroCore during the fourth quarter valued at $82,000. 26.74% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at electroCore
In other news, Director Daniel S. Goldberger sold 16,072 shares of the company’s stock in a transaction on Friday, April 10th. The stock was sold at an average price of $6.02, for a total transaction of $96,753.44. Following the transaction, the director directly owned 291,471 shares of the company’s stock, valued at $1,754,655.42. This represents a 5.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 13.80% of the company’s stock.
Key Headlines Impacting electroCore
Here are the key news stories impacting electroCore this week:
- Positive Sentiment: Brookline Capital Markets raised its FY2026 EPS estimate for electroCore, suggesting slightly better full-year profitability expectations than before. electroCore analyst estimate update
- Positive Sentiment: HC Wainwright maintained a Buy rating and $18 price target, signaling continued bullish longer-term sentiment even as it trimmed some near-term forecasts. electroCore analyst estimate update
- Neutral Sentiment: HC Wainwright lowered its Q2, Q3, Q4 2026 and FY2027 EPS estimates, while Brookline also cut its Q2 and Q4 2026 forecasts, reflecting ongoing expectations for losses in the near term. electroCore analyst estimate update
- Neutral Sentiment: Short interest data showed no meaningful change in the reported share count, so it does not appear to be a major trading catalyst. electroCore short interest update
About electroCore
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Read More
- Five stocks we like better than electroCore
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
